HAVN Competitors

Pink Sheets . USA . 
Stock . HAVN Life Sciences
HAVLF Stock  USD 0.01  0.0002  4.00%   
HAVN Life Sciences competes with Opthea, Molecular Partners, Edgewise Therapeutics, Iteos Therapeutics, and Antibe Therapeutics; as well as few others. The company classifies itself under Healthcare sector and is part of Biotechnology industry. Analyzing HAVN Life competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of HAVN Life to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out HAVN Life Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of HAVN Life competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.00050.26
Details
Intrinsic
Valuation
LowRealHigh
0.00050.26
Details

HAVN Life Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between HAVN Life and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of HAVN and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of HAVN Life Sciences does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
ATBPF
+ 1.0
BIOAF
OPT
+ 0.69
TCBPW
EWTX
+ 0.66
MOLN
ITOS
+ 0.61
OPT
ITOS
+ 0.58
TCBPW
OPT
+ 0.5
PSYBF
  
High negative correlations   
OPT
- 0.85
HAVLF
ITOS
- 0.77
HAVLF
TCBPW
- 0.64
HAVLF
ITOS
- 0.43
MOLN
HAVLF
- 0.41
NMLSF
HAVLF
- 0.39
PSYBF

Risk-Adjusted Indicators

There is a big difference between HAVN Pink Sheet performing well and HAVN Life Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze HAVN Life's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NMLSF  14.44  2.96  0.11 (11.36) 16.00 
(25.50)
 46.77 
(32.81)
 179.73 
PSYBF  623.82  311.91  0.00  3.31  0.00 
 0.00 
 0.00 
 0.00 
 20,998 
HAVLF  152.20  77.06  0.00  8.24  0.00 
 0.00 
 0.00 
 0.00 
 5,104 
TCBPW  20.18  2.82  0.12 (0.79) 19.25 
(26.42)
 42.98 
(33.78)
 130.17 
OPT  2.93 (0.16) 0.00 (0.20) 0.00 
 0.00 
 7.43 
(7.49)
 24.20 
MOLN  4.24  0.30  0.06  0.24  4.48 
(5.72)
 9.38 
(7.22)
 52.92 
EWTX  2.59  0.10  0.03  0.11  3.28 
(2.65)
 6.44 
(5.54)
 26.07 
ITOS  2.24 (0.63) 0.00 (0.37) 0.00 
 0.00 
 4.13 
(4.25)
 15.29 
BIOAF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
ATBPF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
All Fundamental Data

HAVN Life Competitive Analysis

The better you understand HAVN Life competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, HAVN Life's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across HAVN Life's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
HAVLF NMLSF PSYBF TCBPW OPT MOLN EWTX ITOS BIOAF ATBPF
 4.00 
 0.01 
HAVN
 3.69 
 0.02 
Nova
 0.00 
 0.0001 
PsyBio
 31.30 
 0.02 
TCBPW
 3.41 
 3.34 
Opthea
 2.68 
 5.08 
Molecular
 0.06 
 30.78 
Edgewise
 2.77 
 7.42 
Iteos
 0.00 
 0.0001 
BiOasis
 0.00 
 0.22 
Antibe
Market Volatility
(90 Days Market Risk)
Out of control
Out of control
Out of control
Out of control
Moderately volatile
Unstable
Not too volatile
Not too volatile
Very steady
Very steady
Market Performance
(90 Days Performance)
OK
OK
OK
OK
Very Weak
Insignificant
Modest
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
High
High
Below Average
High
Very High
Low
About Average
Low
Very High
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Under Valued
Fairly Valued
Under Valued
Under Valued
Over Valued
Under Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Strong Sell
Cautious Hold
Strong Sell
Cautious Hold
Cautious Hold
Cautious Hold
Hold
Strong Sell
Strong Sell
Current Ratio
0.18
4.5
0.89
0.18
4.97
14.37
27.49
6.42
0.38
14.65
Net Asset
4.06 M
881.16 K
4.01 M
8.93 M
188.79 M
198.35 M
340.04 M
667.59 M
2.27 M
89.16 M
EBITDA
(21.8 M)
(2.93 M)
(10.91 M)
(13.61 M)
(200.02 M)
(59.53 M)
(112.81 M)
(151.1 M)
(3.54 M)
(25.14 M)
Operating Margin
-7.64
N/A
N/A
N/A
N/A
-21.42
N/A
-4.17
-11.41
N/A
Current Valuation
626.96 K
5.46 M
3.69 M
N/A
507.61 M
18.11 M
2.42 B
(212.83 M)
6 M
(19.98 M)
Price To Book
0.21
7.68
202.42
N/A
4.31
1.2
5.95
0.43
53.47
0.61
Retained Earnings
N/A
N/A
N/A
(38.84 M)
(579.7 M)
(191.75 M)
(244.76 M)
124.63 M
(18.69 M)
(12.08 M)
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
874 K
3.96 M
Beta
0.0335
0.86
N/A
0.25
1.54
0.54
0.15
1.39
0.39
0.0997
Number Of Employees
3
4
4
41
33
167
108
157
23
37
Shares Outstanding
8.47 M
143.47 M
80.85 M
N/A
153.89 M
36.86 M
94.69 M
36.53 M
79.41 M
52.14 M
Cash Flow From Operations
(7.88 M)
(1.95 M)
(6.95 M)
(10.54 M)
(161.02 M)
(59.01 M)
(91.95 M)
(103.76 M)
(3.64 M)
(16.92 M)
Total Debt
561.84 K
N/A
207.81 K
1.8 M
141.65 M
3.65 M
5.41 M
6.06 M
401.76 K
205 K
Return On Equity
-2.39
-0.89
-3.1
-12.17
-33.83
-0.37
-0.32
-0.2
N/A
-0.4
Z Score
-16.5
-9.9
7.2
N/A
N/A
N/A
N/A
N/A
-11.5
66.0
Return On Asset
-0.37
-0.52
-0.98
-1.09
-0.83
-0.21
-0.22
-0.13
-0.81
-0.16
Book Value Per Share
0.11
0.007
-0.007
26.11
-0.069
4.18
5.18
17.29
-0.034
0.9
Number Of Shares Shorted
N/A
N/A
N/A
1.19 K
71.94 K
54.74 K
5.74 M
1.96 M
N/A
N/A
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
437 K
2.51 M
Total Asset
4.06 M
881.16 K
4.01 M
8.93 M
188.79 M
198.35 M
340.04 M
667.59 M
2.27 M
89.16 M
Debt To Equity
0.032
N/A
7.03
N/A
N/A
0.02
0.007
0.007
0.31
0.002
Short Ratio
N/A
N/A
N/A
N/A
2.45
4.49
8.93
3.66
N/A
N/A
Target Price
N/A
N/A
N/A
N/A
12.17
10.44
49.43
25.0
0.58
4.53
Shares Owned By Institutions
N/A
0.007
13.23
N/A
3.57
5.31
99.54
99.17
N/A
N/A
Market Capitalization
415.27 K
7.7 M
4.94 M
N/A
529.21 M
187.26 M
2.91 B
271.08 M
2.13 M
22.59 M
Price To Earning
N/A
N/A
N/A
N/A
N/A
1.85
3.45
50.5
13.82
-1.67
Price To Sales
0.98
5730.7
N/A
N/A
2020.97
31.2
N/A
7.75
26.52
2.96
Net Income
(22.44 M)
(2.68 M)
(11.02 M)
(5.91 M)
(220.24 M)
(61.98 M)
(100.16 M)
(112.64 M)
(2.96 M)
(25.06 M)
Earnings Per Share
-0.15
-0.018
-0.089
-0.75
-2.76
-2.12
-1.5
-3.14
-0.031
-0.41
Shares Owned By Insiders
2.77
11.73
25.61
N/A
N/A
N/A
0.46
0.83
2.05
7.79
Revenue
276.47 K
N/A
N/A
N/A
124.67 K
7.04 M
N/A
12.6 M
37.73 K
N/A
Working Capital
N/A
N/A
N/A
950.33 K
124.14 M
178.04 M
310.23 M
510.64 M
437 K
1.45 M
Cash And Equivalents
112.42 K
634.36 K
911.83 K
1.55 M
44.63 M
267.13 M
248.4 M
791.86 M
764.97 K
50.19 M
Cash Per Share
0.02
N/A
0.01
0.08
1.01
8.22
4.99
22.26
0.01
0.96
Gross Profit
89.69 K
(5.44 K)
(1.56 M)
N/A
218.45 K
138.85 M
N/A
267.63 M
(1.15 M)
3.55 M
Day Typical Price
0.0052
0.02
1.0E-4
0.0141
3.37
5.11
31.15
7.34
1.0E-4
0.22
Accumulation Distribution
N/A
0.33
N/A
0.23
0.085
0.025
0.0782
0.0559
N/A
N/A
Market Facilitation Index
N/A
0.0075
N/A
0.0036
0.3
0.13
2.55
0.42
N/A
N/A
Daily Balance Of Power
9.2 T
0.1067
0.0
1.0
0.3667
(1.08)
(0.01)
0.4762
0.0
0.0
Period Momentum Indicator
2.0E-4
8.0E-4
N/A
0.0036
0.11
(0.14)
(0.02)
0.2
N/A
N/A
Rate Of Daily Change
1.04
1.04
1.0
1.31
1.03
0.97
1.0
1.03
1.0
1.0
Day Median Price
0.0052
0.0188
1.0E-4
0.0136
3.38
5.13
31.34
7.3
1.0E-4
0.22
Price Action Indicator
1.0E-4
0.0042
N/A
0.0033
0.015
(0.11)
(0.56)
0.22
N/A
N/A
Coefficient Of Variation
812.38
825.17
819.35
950.84
(3,208)
2028.49
2852.18
(481.98)
N/A
N/A
Mean Deviation
152.2
14.44
623.82
20.18
2.93
4.24
2.59
2.24
N/A
N/A
Jensen Alpha
77.06
2.96
311.91
2.82
(0.16)
0.3011
0.0992
(0.63)
N/A
N/A
Total Risk Alpha
59.69
2.27
241.97
2.01
(0.26)
0.1378
0.0171
(0.67)
N/A
N/A
Sortino Ratio
N/A
0.1127
N/A
0.122
N/A
0.0631
0.03
N/A
N/A
N/A
Downside Variance
N/A
675.72
N/A
497.34
N/A
24.15
11.64
N/A
N/A
N/A
Standard Deviation
627.77
24.45
2572.99
26.18
4.22
6.94
3.84
2.82
N/A
N/A
Kurtosis
66.0
5.75
66.0
0.6709
2.06
14.57
6.92
1.38
N/A
N/A
Potential Upside
N/A
46.77
N/A
42.98
7.43
9.38
6.44
4.13
N/A
N/A
Treynor Ratio
8.24
(11.36)
3.31
(0.79)
(0.20)
0.237
0.1087
(0.37)
N/A
N/A
Maximum Drawdown
5103.85
179.73
20998.0
130.17
24.2
52.92
26.07
15.29
N/A
N/A
Variance
394091.02
597.7
6620260.56
685.31
17.84
48.19
14.75
7.97
N/A
N/A
Market Risk Adjusted Performance
8.25
(11.35)
3.32
(0.78)
(0.19)
0.247
0.1187
(0.36)
N/A
N/A
Risk Adjusted Performance
0.1075
0.1057
0.1067
0.093
(0.02)
0.0479
0.0357
(0.16)
N/A
N/A
Skewness
8.12
1.02
8.12
0.6661
0.4127
2.72
1.49
0.7678
N/A
N/A
Semi Deviation
N/A
16.0
N/A
19.25
N/A
4.48
3.28
N/A
N/A
N/A
Information Ratio
0.123
0.1199
0.122
0.1039
(0.04)
0.0447
0.0267
(0.22)
N/A
N/A
Value At Risk
N/A
(32.81)
N/A
(33.78)
(7.49)
(7.22)
(5.54)
(4.25)
N/A
N/A
Expected Short fall
N/A
(25.50)
N/A
(26.42)
N/A
(5.72)
(2.65)
N/A
N/A
N/A
Downside Deviation
N/A
25.99
N/A
22.3
N/A
4.91
3.41
N/A
N/A
N/A
Semi Variance
N/A
256.02
N/A
370.45
N/A
20.08
10.77
N/A
N/A
N/A

HAVN Life Competition Performance Charts

Five steps to successful analysis of HAVN Life Competition

HAVN Life's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by HAVN Life Sciences in relation to its competition. HAVN Life's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of HAVN Life in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact HAVN Life's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to HAVN Life Sciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your HAVN Life position

In addition to having HAVN Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Wireless Thematic Idea Now

Wireless
Wireless Theme
Companies providing wireless technology and communication services. The Wireless theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wireless Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in HAVN Pink Sheet

HAVN Life financial ratios help investors to determine whether HAVN Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HAVN with respect to the benefits of owning HAVN Life security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY